Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs

Publication year
2018
Author(s)
Zuur, M.A.
Pasipanodya, J.G.
Soolingen, D. van
Werf, T.S. van der
Gumbo, T.
Alffenaar, J.W.C.
Source
Clinical Infectious Diseases, 67, 11, (2018), pp. 1743-1749
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/199484   https://hdl.handle.net/2066/199484
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.